Authors:
MARSHMAN E
NEWELL DR
CALVERT AH
DICKINSON AM
PATEL HRH
CAMPBELL FC
CURTIN NJ
Citation: E. Marshman et al., DIPYRIDAMOLE POTENTIATES ANTIPURINE ANTIFOLATE ACTIVITY IN THE PRESENCE OF HYPOXANTHINE IN TUMOR-CELLS BUT NOT IN NORMAL-TISSUES IN-VITRO, Clinical cancer research, 4(11), 1998, pp. 2895-2902
Authors:
ALMASSY R
BOWMAN K
CALVERT AH
CURTIN NJ
GOLDING BT
HOSTOMSKA Z
HOSTOMSKY Z
GRIFFIN RJ
MAEGLEY K
NEWELL DR
SRINIVASAN S
WHITE AW
WEBBER S
Citation: R. Almassy et al., 2-PHENYLBENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT INHIBITORS OF THE DNA-REPAIR ENZYME POLY(ADP-RIBOSE)-POLYMERASE (PARP), Annals of oncology, 9, 1998, pp. 116-116
Authors:
MONKS NR
NEWELL DR
CURTIN NJ
BLAKEY DC
EAST SJ
HEUZE A
Citation: Nr. Monks et al., INDUCTION OF APOPTOSIS IN LOVO COLORECTAL CELLS BY THE ADEPT SYSTEM ZD2767 - A COMPARISON WITH CHLORAMBUCIL AND A MONO-FUNCTIONAL ZD2767 ANALOG, Annals of oncology, 9, 1998, pp. 430-430
Authors:
SMITH PG
NEWELL DR
BARNES MJ
CALVERT AH
CURTIN NJ
Citation: Pg. Smith et al., POTENTIATION OF THE IN-VITRO ACTIVITY OF THE MULTITARGETED ANTIFOLATEMTA (LY231514) BY DIPYRIDAMOLE, Annals of oncology, 9, 1998, pp. 588-588
Authors:
MARSHMAN E
CALVERT AH
NEWELL DR
CURTIN NJ
Citation: E. Marshman et al., DIPYRIDAMOLE SELECTIVELY POTENTIATES ANTIPURINE ANTIFOLATES IN HUMAN TUMOR-CELL LINES BUT NOT NORMAL TISSUE TARGETS OF DOSE-LIMITING TOXICITY, Annals of oncology, 9, 1998, pp. 589-589
Authors:
BOWMAN KJ
WHITE A
GOLDING BT
GRIFFIN RJ
CURTIN NJ
Citation: Kj. Bowman et al., POTENTIATION OF ANTICANCER AGENT CYTOTOXICITY BY THE POTENT POLY(ADP-RIBOSE) POLYMERASE INHIBITORS NU1025 AND NU1064, British Journal of Cancer, 78(10), 1998, pp. 1269-1277
Citation: Rn. Turner et al., SELECTIVE POTENTIATION OF LOMETREXOL GROWTH-INHIBITION BY DIPYRIDAMOLE THROUGH CELL-SPECIFIC INHIBITION OF HYPOXANTHINE SALVAGE, British Journal of Cancer, 76(10), 1997, pp. 1300-1307
Citation: Rn. Turner et Nj. Curtin, DIPYRIDAMOLE INCREASES VP16 GROWTH-INHIBITION, ACCUMULATION AND RETENTION IN PARENTAL AND MULTIDRUG-RESISTANT CHO CELLS, British Journal of Cancer, 73(7), 1996, pp. 856-860
Citation: Rj. Graffin et al., THE ROLE OF INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE AS RESISTANCE-MODIFYING AGENTS IN CANCER-THERAPY, Biochimie, 77(6), 1995, pp. 408-422
Authors:
GRIFFIN RJ
PEMBERTON LC
RHODES D
BLEASDALE C
BOWMAN K
CALVERT AH
CURTIN NJ
DURKACZ BW
NEWELL DR
PORTEOUS JK
GOLDING BT
Citation: Rj. Griffin et al., NOVEL POTENT INHIBITORS OF THE DNA-REPAIR ENZYME POLY(ADP-RIBOSE)POLYMERASE (PARP), Anti-cancer drug design, 10(6), 1995, pp. 507-514
Authors:
BOULTON S
PEMBERTON LC
PORTEOUS JK
CURTIN NJ
GRIFFIN RJ
GOLDING BT
DURKACZ BW
Citation: S. Boulton et al., POTENTIATION OF TEMOZOLOMIDE-INDUCED CYTOTOXICITY - A COMPARATIVE-STUDY OF THE BIOLOGICAL EFFECTS OF POLY(ADP-RIBOSE) POLYMERASE INHIBITORS, British Journal of Cancer, 72(4), 1995, pp. 849-856
Authors:
ARRIS CE
BLEASDALE C
CALVERT AH
CURTIN NJ
DALBY C
GOLDING BT
GRIFFIN RJ
LUNN JM
MAJOR GN
NEWELL DR
Citation: Ce. Arris et al., PROBING THE ACTIVE-SITE AND MECHANISM OF ACTION OF O-6-METHYLGUANINE-DNA METHYLTRANSFERASE WITH SUBSTRATE-ANALOGS TO (O-6-SUBSTITUTED GUANINES), Anti-cancer drug design, 9(5), 1994, pp. 401-408